INDV
Indivior PLC Ordinary Shares
NASDAQ: INDV · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$37.83
+5.10% today
Updated 2026-06-03
Market cap
$4.45B
P/E ratio
19.29
P/S ratio
3.45x
EPS (TTM)
$1.95
Dividend yield
—
52W range
$13 – $41
Volume
2.0M
WallStSmart proprietary scores
62
out of 100
Grade: C+
Hold
Investment rating
8.7
Growth
A5.5
Quality
C+8.5
Profitability
A5.3
Valuation
C+5/9
Piotroski F-Score
Moderate
1.3
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$51.50
+36.14%
12-Month target
$37.43
-1.06%
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy5 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Revenue growth 19.20% QoQ
+ Debt/equity -3.53x — low leverage
Risks
- Altman Z 1.26 — distress zone
- Negative free cash flow $-29.00M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $901.00M | $1.09B | $1.19B | $1.24B | $1.29B |
| Net income | $-44.00M | $-129.00M | $2.00M | $210.00M | $89.00M |
| EPS | — | — | — | — | $1.95 |
| Free cash flow | $-9.00M | $-353.00M | $7.00M | $-93.00M | $-29.00M |
| Profit margin | -4.88% | -11.80% | 0.17% | 16.95% | 19.50% |
Peer comparison
Smart narrative
Indivior PLC Ordinary Shares trades at $37.83. representing a P/E of 19.29x trailing earnings. Our Smart Value Score of 62/100 indicates the stock is good. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of 1.26, it sits in the distress. TTM revenue stands at $1.29B. with profit margins at 19.50%.
Frequently asked questions
What is Indivior PLC Ordinary Shares's stock price?
Indivior PLC Ordinary Shares (INDV) trades at $37.83, on a P/E of 19.3x and a P/S of 3.4x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Indivior PLC Ordinary Shares overvalued?
Indivior PLC Ordinary Shares carries a Smart Value Score of 62/100 (Grade C+), which we rate Hold. That score blends growth, quality, and valuation into one read.
What is the price target of Indivior PLC Ordinary Shares (INDV)?
The 12-month analyst consensus target is $51.50, about 36.1% above the current $37.83. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is Indivior PLC Ordinary Shares's revenue?
Indivior PLC Ordinary Shares's trailing twelve-month revenue is $1.29B. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Indivior PLC Ordinary Shares's Altman Z-Score is 1.26, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio3.45x
ROE12.20%
Beta1.17
50D MA$34.46
200D MA$31.27
Shares out0.12B
Float0.11B
Short ratio—
Avg volume2.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—